Morning Overview on MSN
A next-generation CAR-T therapy wiped out glioblastoma, the deadliest adult brain cancer, in lab tests of tumors that almost always shrug off treatment
Researchers have engineered CAR-T cells armed with computationally designed protein binders that eliminated glioblastoma ...
Morning Overview on MSN
Disabling a single protein called NFIL3 kept CAR T-cells fighting tumors longer in a screen of 400 transcription factors
Researchers screening roughly 400 transcription factors found that disabling a single protein, NFIL3, allowed CAR T-cells to ...
Sequencing CAR T-cell therapy versus bispecific antibodies in myeloma increasingly hinges on MRD depth, transplant candidacy, ...
A pioneering clinical trial has successfully enabled two patients with end-stage kidney disease to receive previously ...
T cells are some of the immune system's most important warriors. They can stop tumor growth and even fight off severe ...
A blood test following CAR T-cell therapy for relapsed/refractory mantle cell lymphoma (MCL) appears to do a better job than PET-CT scans at predicting which patients have poor prognoses, a small, ...
A pioneering clinical trial has successfully enabled two patients with end-stage kidney disease to receive previously ...
It develops from the abnormal multiplication of T cells, or T-lymphocytes, a type of white blood cell essential for immune system function. The specific treatment course and prognosis for T-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results